CSIMarket
 


Respirerx Pharmaceuticals Inc   (RSPI)
Other Ticker:  
 

Cumulative Respirerx Pharmaceuticals Inc 's Quick Ratio for Trailing Twelve Months Period

RSPI's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

RSPI Quick Ratio for Trailing Twelve Months Period

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Growth 11.25 % 14.76 % 18.21 % 22.68 % 22.5 %
Y / Y Cash & cash equivalent Growth 34761.9 % -45.24 % -93.71 % -89.21 % -99.93 %
Quick Ratio for Trailing Twelve Months Period 0 0 0 0 0
Total Ranking # 4214 # 4410 # 5027 # 4830 # 5803
Seq. Current Liabilities Growth -0.63 % 4.76 % 2.55 % 4.21 % 2.5 %
Seq. Cash & cash equivalent Growth 5205.07 % 56.82 % 46.67 % 185.71 % -91.67 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2023
On the trailing twelve months basis Despite decrease in Current Liabilities in the II. Quarter to $12 millions, average cumulative Quick Ratio for Trailing Twelve Months Period